Top 5 Life Sciences Stocks To Invest In 2014

Expert healthcare company watcher Andrew Fein of H.C. Wainwright & Co. knows how the sausage is made in the stock analyst factory. And he doesn't pull any punches: In this interview with The Life Sciences Report, Fein dishes out praise for sticking to sellside fundamentals and suggests skimming off bloggers who have yet to earn their analytical chops. He rounds out the menu by naming biotech companies with the potential to rise to the top of the simmering biotech market.

The Life Sciences Report: How has the nature of biotech investing changed since you began analyzing healthcare biotech equities in 2000?

Andrew Fein: Clearly, the web as a source of "investment analytics" is a new paradigm. With so much collectively generated information available on the web, investors are forgetting to analyze individual data points, such as talking directly to physicians and medical experts. Folks who write opinionated investment blogs and emit endless Twitter streams are disproportionately influencing the movement of stocks outside of the traditional analytical Wall Street paradigm. There is always room for new and thoughtful analysis, but it is troubling when the background of the source of what is promoted as important information is unclear. And, unfortunately, hidden biases and agendas often influence the opinion of the non-traditional analyst - such as trying to pump up his or her book.

Top Small Cap Stocks To Buy Right Now: Northland Power Inc (NPIFF.PK)

Northland Power Inc. (Northland) owns or has an economic interests, through its subsidiaries, in operating power-producing facilities and a pipeline of construction and development projects. Its operating assets consist of facilities, which produce electricity from natural gas and renewable sources. Its subsidiaries include Iroquois Falls Corp., which owns the Iroquois Falls Facility; Kingston LP, which owns the Kingston Facility; Thorold LP, which owns the Thorold Facility; Mont Miller LP; Jardin LP, which owns the Jardin wind farm; DK Windpark Kavelstorf GmbH & Co. KG and DK Burgerwindpark Eckolstadt GmbH & Co. KG, which own the German Wind Farms; Mont Louis LP, which owns the Mont Louis Wind Farm; Spy Hill LP, which owns the Spy Hill Facility, and North Battleford LP, which owns the North Battleford Facility. Northland owns a 19% interest in Panda Energy Corporation, which through its wholly owned subsidiaries owns the 230 mega-watts combined-cycle Panda-Brandywine facility. Advisors' Opinion:

• [By Markus Aarnio]

  Emera's competitors include Northland Power (NPIFF.PK), Fortis (FRTSF.PK), and Atlantic Power (AT). Northland Power has seen insider buying in August and has a dividend yield of 7.6%. Fortis has seen both insider buying and insider selling in August. Fortis has a dividend yield of 4.1%. Atlantic Power saw insider buying last time in April. Atlantic Power has a dividend yield of 9.4%.

Top 5 Life Sciences Stocks To Invest In 2014: Staples Inc.(SPLS)

Staples, Inc., together with its subsidiaries, operates as an office products company. The company offers various office supplies and services, office machines and related products, computers and related products, and office furniture under Staples, Quill, and other proprietary brands. It also provides copy and print services to retail and delivery customers, as well as technology services through its EasyTech business. The company sells and delivers office products and services directly to businesses and consumers through Internet retail, including Staples.com and Quill.com, as well as through contract sales force, direct mail catalog business, and retail stores. As of January 28, 2012, it operated 2,295 retail stores in 48 states and the District of Columbia in the United States; and 10 provinces and 2 territories in Canada, as well as in Belgium, Finland, Germany, the Netherlands, Norway, Portugal, Sweden, the United Kingdom, China, Argentina, and Australia. The company also operated 124 distribution and fulfillment centers in 29 states in the United States; 7 provinces in Canada; and in Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Spain, Sweden, the United Kingdom, China, Argentina, Brazil, and Australia. Staples, Inc. was founded in 1986 and is based in Framingham, Massachusetts.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  Top Headline
  Staples (NASDAQ: SPLS) reported weaker-than-expected fiscal fourth-quarter earnings and announced its plans to close 225 stores by 2015. Staples posted its quarterly earnings of $212 million, or $0.33 per share, up from $90 million, or $0.14 per share, in the year-earlier quarter. On an adjusted basis, it earned $0.33 per share, versus analysts' estimates of $0.38 per share. Its sales fell to $5.87 billion from $6.57 billion.

• [By Mani]

  [Related -Bullish Activity Detected In Staples, Inc. (SPLS) Options and Bearish in Carnival Corporation (CCL)]

  The situation led to industry consolidation, with Office Depot and OfficeMax agreeing to merge in $1.17 billion deal. In a way, these could be beneficial for Staples as it may gain market share from those two rivals who are in their integration phase.

• [By Steve Symington]

  Stapling it all together
  Now, Staples (NASDAQ: SPLS  ) has become the first major U.S. retailer to carry 3-D printers by offering 3D Systems' very own Cube printers online.

Top 5 Life Sciences Stocks To Invest In 2014: First Trust Exchange Traded Fund (FVL)

First Trust Value Line 100 Fund (the Fund) is a diversified closed-end management investment company. The Fund seeks to outperform the Standard & Poor's 500 Composite Stock Price Index (the S&P 500 Index) by adhering to a strategy of investing in a diversified portfolio of the 100 common stocks ranked number 1 in Value Line's Timeliness Ranking System. The Fund invests 80% of its net assets in the stocks that are ranked number one in the Value Line Timeliness Ranking System. As of March 31, 2006, the Fund had invested in sectors, such as household durables, metals and mining, specialty retail, oil and gas, software, machinery, hotels, restaurants and leisure, computers and peripherals, biotechnology, information technology services, and textiles, apparel and luxury goods.

As of March 31, 2006, the Fund's top 10 holdings were Palm, Inc., United INDL Corp., AAR Corp., Accenture LTD, Citrix Systems, Inc., Cymer Inc., Guess, Inc., Henry Jack & Assoc., Inc., Micrel Inc. and Molecular Devices Corp. The Fund had a large capitalization orientation to its portfolio holdings as of December 31, 2005. As of December 31, 2005, the 100 stocks in the portfolio consisted of large-cap stocks (34), mid-cap stocks (35) and small-cap stocks (31). During the year ended December 31, 2005, the Fund posted a net asset value (NAV) total return of 11.9% and a market value total return of 7.5%. This compared to a gain of 4.8% for the S&P 500 Index. The Fund's investment advisor is First Trust Advisors, L.P.

Advisors' Opinion:

• [By David Trainer]

  First Trust Value Line 100 ETF (FVL) is in the Danger Zone this week. FVL is another example of a supposedly "passive" ETF that purportedly tracks an index but actually resembles an actively managed portfolio. FVL's methodology tracks an index, but it is an index in name only.

• [By David Trainer]

  First Trust Value Line 100 ETF (FVL) is my worst-rated All Cap Blend ETF and Clarity Fund (CLRTX) is my worst-rated All Cap Blend mutual fund. FVL earns my Dangerous rating, while CLRTX gets my Very Dangerous rating.

Top 5 Life Sciences Stocks To Invest In 2014: Oncothyreon Inc .(ONTY)

Oncothyreon Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic products for the treatment of cancer. Its primary product candidate, Stimuvax is in two phase III clinical trials for the treatment of non-small cell lung cancer. The company is also developing PX-866, a small molecule that is in phase II trials for various cancer indications. In addition, it engages in the preclinical development of ONT-10, a cancer vaccine; and ONT-701, a pan-inhibitor of the B-cell lymphoma-2 family of anti-apoptotic proteins. The company operates primarily in the United States and Canada. Oncothyreon Inc. was founded in 1985 and is headquartered in Seattle, Washington.

Advisors' Opinion:

• [By Lauren Pollock]

  Among the companies with shares expected to actively trade in Wednesday’s session are Mako Surgical Corp.(MAKO), Ascena Retail Group Inc.(ASNA) and Oncothyreon Inc.(ONTY)

• [By Ant贸nio Costa]

  Oncothyreon Inc (NASDAQ: ONTY) is firming just above key support at $1.78 and a triangle has taken shape over the last few weeks. The stock is starting to show signs of accumulation with high upside days and low downside days. This stock is poised for a move and I suspect that it will explode to the upside. In addition, Inside trading has been very active over the last month. They are buying now after pausing years.